Jun Dai

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinoma.

Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 10, 2025

Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugates.

Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugates.

Journal: Cancer letters

Published: April 28, 2025

Single-Cell Lineage Tracing Uncovers Resistance Signatures and Sensitizing Strategies to FLT3 Inhibitors in Acute Myeloid Leukemia.

Single-Cell Lineage Tracing Uncovers Resistance Signatures and Sensitizing Strategies to FLT3 Inhibitors in Acute Myeloid Leukemia.

Journal: Cancer research

Published: October 10, 2024

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma.

Journal: BMC cancer

Published: October 25, 2023

Tracing back primed resistance in cancer via sister cells.

Tracing back primed resistance in cancer via sister cells.

Journal: Nature communications

Published: April 25, 2023

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.

Journal: Developmental cell

Published: April 22, 2022

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.

Journal: Science advances

Published: February 23, 2022

PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples.

PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples.

Journal: Bioinformatics (Oxford, England)

Published: December 07, 2020

The Plasticity of Mesenchymal Stem Cells in Regulating Surface HLA-I.

The Plasticity of Mesenchymal Stem Cells in Regulating Surface HLA-I.

Journal: iScience

Published: October 23, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026